about
Seven fractions to deliver partial breast irradiation: the toxicity is LowThe Role of B-RAF Mutations in Melanoma and the Induction of EMT via Dysregulation of the NF-κB/Snail/RKIP/PTEN CircuitImproved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approachesThe involvement of the transcription factor Yin Yang 1 in cancer development and progression.Understanding rituximab function and resistance: implications for tailored therapy.CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.Retreatment with trastuzumab after progression on lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single-institution experience.Prognosis of women with primary breast cancer diagnosed during pregnancy.IL-6-174 G > C and MMP-9-1562 C > T polymorphisms are associated with increased risk of deep vein thrombosis in cancer patients.Local High-Dose Radiotherapy Induces Systemic Immunomodulating Effects of Potential Therapeutic Relevance in Oligometastatic Breast Cancer.Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial.
P50
Q33721910-0DBA5788-300F-4AEC-A6CC-2B3E91DAFBEFQ34106285-A101B4AF-EFE6-4A3F-B2C8-2F05BFDF996FQ35789363-049010BC-B57E-40A2-A852-74AFE791880FQ36870100-CDC5BA25-082B-41E4-8117-F43B415F3A07Q37192606-B7F39005-EE3C-47D8-AAFF-82D8415903EFQ37431346-78935702-6B11-4D8E-A80A-91BE24D6B847Q37825178-655F69DE-7E2A-4938-9EEE-677EC9C3669DQ38639827-B0CE8671-DCA9-4F87-8865-95735B728FECQ39566838-73B2A658-4905-47DD-9BF4-A5DCBEC73CFEQ41421332-2804792E-BB09-424D-921B-6B4F511F152EQ43441522-3201547F-1BF3-4662-A9B3-7101A36C9451Q43881537-BE32C7AD-900F-4AE2-9F4A-1600347F022BQ47115510-AB45DCCC-472D-4F76-B102-98773797E4F1Q47931888-F3E2072C-3B71-469B-995E-39A7FFB9FF21
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Loredana Militello
@ast
Loredana Militello
@en
Loredana Militello
@es
Loredana Militello
@nl
Loredana Militello
@sl
type
label
Loredana Militello
@ast
Loredana Militello
@en
Loredana Militello
@es
Loredana Militello
@nl
Loredana Militello
@sl
prefLabel
Loredana Militello
@ast
Loredana Militello
@en
Loredana Militello
@es
Loredana Militello
@nl
Loredana Militello
@sl
P106
P1153
26632972800
P31
P496
0000-0002-8739-9602